Zoetis Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Zoetis Inc. (ZTS) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 437.89 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-06
- Zoetis Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- Zoetis Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 437.89K shares, a 39.49% increase year-over-year.
- Zoetis Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- Zoetis Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- Zoetis Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 320.50K shares, a 16.09% increase from fiscal 2024.
- Zoetis Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 276.09K shares, a 1.82% increase from fiscal 2023.
- Zoetis Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 271.15K shares, a 14.94% increase from fiscal 2022.
- Zoetis Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 235.90K shares, a 16.99% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 437.89K shares 10-Q · filed 2026-08-06 | 437.89K shares derived: sum of 3 quarters · filed 2026-08-06 | 437.89K shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 437.89K shares 10-Q · filed 2026-05-07 | 437.89K shares derived: sum of 2 quarters · filed 2026-05-07 | 437.89K shares derived: sum of 3 quarters · filed 2026-05-07 | 444.47K shares derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | 0.00 shares derived: sum of 2 quarters · filed 2026-02-12 | 6.58K shares derived: sum of 3 quarters · filed 2026-02-12 | 320.50K shares 10-K · filed 2026-02-12 |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | 6.58K shares derived: sum of 2 quarters · filed 2025-11-04 | 320.50K shares 10-Q · filed 2025-11-04 | 326.13K shares derived: sum of 4 quarters · filed 2025-11-04 |
| 2025-06-30 | 6.58K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | 320.50K shares 10-Q · filed 2025-08-05 | 326.13K shares derived: sum of 3 quarters · filed 2025-08-05 | 330.06K shares derived: sum of 4 quarters · filed 2025-08-05 |
| 2025-03-31 | 313.92K shares 10-Q · filed 2025-05-06 | 319.55K shares derived: sum of 2 quarters · filed 2025-05-06 | 323.48K shares derived: sum of 3 quarters · filed 2025-05-06 | 324.20K shares derived: sum of 4 quarters · filed 2025-05-06 |
| 2024-12-31 | 5.64K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | 9.56K shares derived: sum of 2 quarters · filed 2025-02-13 | 10.29K shares derived: sum of 3 quarters · filed 2025-02-13 | 276.09K shares 10-K · filed 2025-02-13 |
| 2024-09-30 | 3.92K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | 4.65K shares derived: sum of 2 quarters · filed 2024-11-04 | 270.45K shares 10-Q · filed 2024-11-04 | 270.45K shares derived: sum of 4 quarters · filed 2024-11-04 |
| 2024-06-30 | 726.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | 266.53K shares 10-Q · filed 2024-08-06 | 266.53K shares derived: sum of 3 quarters · filed 2024-08-06 | 266.53K shares derived: sum of 4 quarters · filed 2024-08-06 |
| 2024-03-31 | 265.80K shares 10-Q · filed 2024-05-02 | 265.80K shares derived: sum of 2 quarters · filed 2024-05-02 | 265.80K shares derived: sum of 3 quarters · filed 2024-05-02 | 268.94K shares derived: sum of 4 quarters · filed 2024-05-02 |
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | 0.00 shares derived: sum of 2 quarters · filed 2024-02-13 | 3.14K shares derived: sum of 3 quarters · filed 2024-02-13 | 271.15K shares 10-K · filed 2024-02-13 |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | 3.14K shares derived: sum of 2 quarters · filed 2023-11-02 | 271.15K shares 10-Q · filed 2023-11-02 | 271.15K shares derived: sum of 4 quarters · filed 2023-11-02 |
| 2023-06-30 | 3.14K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | 271.15K shares 10-Q · filed 2023-08-08 | 271.15K shares derived: sum of 3 quarters · filed 2023-08-08 | 271.15K shares derived: sum of 4 quarters · filed 2023-08-08 |
| 2023-03-31 | 268.01K shares 10-Q · filed 2023-05-04 | 268.01K shares derived: sum of 2 quarters · filed 2023-05-04 | 268.01K shares derived: sum of 3 quarters · filed 2023-05-04 | 268.67K shares derived: sum of 4 quarters · filed 2023-05-04 |
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | 0.00 shares derived: sum of 2 quarters · filed 2023-02-14 | 665.00 shares derived: sum of 3 quarters · filed 2023-02-14 | 235.90K shares 10-K · filed 2023-02-14 |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | 665.00 shares derived: sum of 2 quarters · filed 2022-11-03 | 235.90K shares 10-Q · filed 2022-11-03 | 235.90K shares derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-06-30 | 665.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | 235.90K shares 10-Q · filed 2022-08-04 | 235.90K shares derived: sum of 3 quarters · filed 2022-08-04 | 235.90K shares derived: sum of 4 quarters · filed 2022-08-04 |
| 2022-03-31 | 235.24K shares 10-Q · filed 2022-05-05 | 235.24K shares derived: sum of 2 quarters · filed 2022-05-05 | 235.24K shares derived: sum of 3 quarters · filed 2022-05-05 | 237.76K shares derived: sum of 4 quarters · filed 2022-05-05 |
| 2021-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | 0.00 shares derived: sum of 2 quarters · filed 2022-02-15 | 2.52K shares derived: sum of 3 quarters · filed 2022-02-15 | 284.20K shares 10-K · filed 2022-02-15 |
| 2021-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | 2.52K shares derived: sum of 2 quarters · filed 2021-11-04 | 284.20K shares 10-Q · filed 2021-11-04 | 301.44K shares derived: sum of 4 quarters · filed 2021-11-04 |
| 2021-06-30 | 2.52K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | 284.20K shares 10-Q · filed 2021-08-05 | 301.44K shares derived: sum of 3 quarters · filed 2021-08-05 | 301.44K shares derived: sum of 4 quarters · filed 2021-08-05 |
| 2021-03-31 | 281.68K shares 10-Q · filed 2021-05-06 | 298.92K shares derived: sum of 2 quarters · filed 2021-05-06 | 298.92K shares derived: sum of 3 quarters · filed 2021-05-06 | 311.81K shares derived: sum of 4 quarters · filed 2021-05-06 |
| 2020-12-31 | 17.25K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | 17.25K shares derived: sum of 2 quarters · filed 2021-02-16 | 30.13K shares derived: sum of 3 quarters · filed 2021-02-16 | 309.97K shares 10-K · filed 2021-02-16 |
| 2020-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | 12.88K shares derived: sum of 2 quarters · filed 2020-11-05 | 292.73K shares 10-Q · filed 2020-11-05 | 294.10K shares derived: sum of 4 quarters · filed 2020-11-05 |
| 2020-06-30 | 12.88K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | 292.73K shares 10-Q · filed 2020-08-06 | 294.10K shares derived: sum of 3 quarters · filed 2020-08-06 | 294.10K shares derived: sum of 4 quarters · filed 2020-08-06 |
| 2020-03-31 | 279.84K shares 10-Q · filed 2020-05-06 | 281.21K shares derived: sum of 2 quarters · filed 2020-05-06 | 281.21K shares derived: sum of 3 quarters · filed 2020-05-06 | 289.25K shares derived: sum of 4 quarters · filed 2020-05-06 |
| 2019-12-31 | 1.37K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | 1.37K shares derived: sum of 2 quarters · filed 2020-02-13 | 9.41K shares derived: sum of 3 quarters · filed 2020-02-13 | 446.16K shares 10-K · filed 2020-02-13 |
| 2019-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | 8.04K shares derived: sum of 2 quarters · filed 2019-11-07 | 444.79K shares 10-Q · filed 2019-11-07 | 444.79K shares derived: sum of 4 quarters · filed 2019-11-07 |
| 2019-06-30 | 8.04K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | 444.79K shares 10-Q · filed 2019-08-06 | 444.79K shares derived: sum of 3 quarters · filed 2019-08-06 | 444.79K shares derived: sum of 4 quarters · filed 2019-08-06 |
| 2019-03-31 | 436.75K shares 10-Q · filed 2019-05-02 | 436.75K shares derived: sum of 2 quarters · filed 2019-05-02 | 436.75K shares derived: sum of 3 quarters · filed 2019-05-02 | 439.50K shares derived: sum of 4 quarters · filed 2019-05-02 |
| 2018-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | 0.00 shares derived: sum of 2 quarters · filed 2019-02-14 | 2.75K shares derived: sum of 3 quarters · filed 2019-02-14 | 538.82K shares 10-K · filed 2019-02-14 |
| 2018-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | 2.75K shares derived: sum of 2 quarters · filed 2018-11-01 | 538.82K shares 10-Q · filed 2018-11-01 | 540.78K shares derived: sum of 4 quarters · filed 2018-11-01 |
| 2018-06-30 | 2.75K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | 538.82K shares 10-Q · filed 2018-08-02 | 540.78K shares derived: sum of 3 quarters · filed 2018-08-02 | 544.99K shares derived: sum of 4 quarters · filed 2018-08-02 |
| 2018-03-31 | 536.07K shares 10-Q · filed 2018-05-02 | 538.03K shares derived: sum of 2 quarters · filed 2018-05-02 | 542.24K shares derived: sum of 3 quarters · filed 2018-05-02 | 551.60K shares derived: sum of 4 quarters · filed 2018-05-02 |
| 2017-12-31 | 1.96K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | 6.17K shares derived: sum of 2 quarters · filed 2018-02-15 | 15.53K shares derived: sum of 3 quarters · filed 2018-02-15 | 718.28K shares 10-K · filed 2018-02-15 |
| 2017-10-01 | 4.21K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | 13.58K shares derived: sum of 2 quarters · filed 2017-11-02 | 716.32K shares 10-Q · filed 2017-11-02 | 738.61K shares derived: sum of 4 quarters · filed 2017-11-02 |
| 2017-07-02 | 9.37K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | 712.11K shares 10-Q · filed 2017-08-08 | 734.40K shares derived: sum of 3 quarters · filed 2017-08-08 | 777.37K shares derived: sum of 4 quarters · filed 2017-08-08 |
| 2017-04-02 | 702.75K shares 10-Q · filed 2017-05-04 | 725.03K shares derived: sum of 2 quarters · filed 2017-05-04 | 768.00K shares derived: sum of 3 quarters · filed 2017-05-04 | 777.87K shares derived: sum of 4 quarters · filed 2017-05-04 |
| 2016-12-31 | 22.29K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | 65.26K shares derived: sum of 2 quarters · filed 2017-02-16 | 75.12K shares derived: sum of 3 quarters · filed 2017-02-16 | 952.73K shares 10-K · filed 2017-02-16 |
| 2016-10-02 | 42.97K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | 52.83K shares derived: sum of 2 quarters · filed 2016-11-03 | 930.44K shares 10-Q · filed 2016-11-03 | 930.44K shares derived: sum of 4 quarters · filed 2016-11-03 |
| 2016-07-03 | 9.87K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | 887.47K shares 10-Q · filed 2016-08-05 | 887.47K shares derived: sum of 3 quarters · filed 2016-08-05 | 892.16K shares derived: sum of 4 quarters · filed 2016-08-05 |
| 2016-04-03 | 877.61K shares 10-Q · filed 2016-05-06 | 877.61K shares derived: sum of 2 quarters · filed 2016-05-06 | 882.30K shares derived: sum of 3 quarters · filed 2016-05-06 | 883.91K shares derived: sum of 4 quarters · filed 2016-05-06 |
| 2015-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | 4.69K shares derived: sum of 2 quarters · filed 2016-02-24 | 6.30K shares derived: sum of 3 quarters · filed 2016-02-24 | 862.40K shares 10-K · filed 2016-02-24 |
| 2015-09-27 | 4.69K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | 6.30K shares derived: sum of 2 quarters · filed 2015-11-05 | 862.40K shares 10-Q · filed 2015-11-05 | 862.40K shares derived: sum of 4 quarters · filed 2015-11-05 |
| 2015-06-28 | 1.61K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | 857.72K shares 10-Q · filed 2015-08-06 | 857.72K shares derived: sum of 3 quarters · filed 2015-08-06 | 914.55K shares derived: sum of 4 quarters · filed 2015-08-06 |
| 2015-03-29 | 856.11K shares 10-Q · filed 2015-05-07 | 856.11K shares derived: sum of 2 quarters · filed 2015-05-07 | 912.94K shares derived: sum of 3 quarters · filed 2015-05-07 | 961.64K shares derived: sum of 4 quarters · filed 2015-05-07 |
| 2014-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | 56.83K shares derived: sum of 2 quarters · filed 2015-02-27 | 105.53K shares derived: sum of 3 quarters · filed 2015-02-27 | 3.01M shares 10-K · filed 2015-02-27 |
| 2014-09-28 | 56.83K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | 105.53K shares derived: sum of 2 quarters · filed 2014-11-10 | 3.01M shares 10-Q · filed 2014-11-10 | 3.01M shares derived: sum of 4 quarters · filed 2014-11-10 |
| 2014-06-29 | 48.70K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | 2.95M shares 10-Q · filed 2014-08-12 | 2.95M shares derived: sum of 3 quarters · filed 2014-08-12 | 66.51K shares derived: sum of 4 quarters · filed 2014-08-12 |
| 2014-03-30 | 2.90M shares 10-Q · filed 2014-05-13 | 2.90M shares derived: sum of 2 quarters · filed 2014-05-13 | 17.81K shares derived: sum of 3 quarters · filed 2014-05-13 | 2.97M shares derived: sum of 4 quarters · filed 2014-05-13 |
| 2013-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26 | -2.88M shares derived: sum of 2 quarters · filed 2014-03-26 | 65.87K shares derived: sum of 3 quarters · filed 2014-03-26 | 2.99M shares 10-K · filed 2014-03-26 |
| 2013-09-29 | -2.88M shares derived: 10-K 12 month − 3 quarters · filed 2014-03-26 | 65.87K shares derived: sum of 2 quarters · filed 2014-03-26 | 2.99M shares 10-Q · filed 2013-11-13 | |
| 2013-06-30 | 2.95M shares 10-Q · filed 2013-08-14 | 5.88M shares derived: sum of 2 quarters · filed 2013-08-14 | ||
| 2013-03-31 | 2.93M shares 10-Q · filed 2013-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |